Avai Bio (AVAI) Assets Average (2018 - 2025)

Avai Bio has disclosed Assets Average across 8 years of filings, most recently posting $202142.0 for Q4 2025.

• Assets Average for Q4 2025 came in at $202142.0, up 13.59% year-over-year; the trailing twelve-month figure through Dec 2025 was $202142.0 (up 13.59% YoY), and the FY2025 annual result was $273379.5, down 2.97% from the prior year.
• Assets Average came in at $202142.0 for Q4 2025 at Avai Bio, up from $188339.0 in the prior quarter.
• In the past five years, Assets Average ranged from a high of $844125.0 in Q2 2021 to a low of $177959.5 in Q4 2024.
• The 5-year median for Assets Average is $280803.8 (2023), against an average of $364008.4.
• Across the five-year window, Assets Average soared 147.43% in 2021 and slumped 53.66% in 2022, its largest moves.
• Avai Bio's Assets Average stood at $562438.5 in 2021, then slumped by 44.57% to $311768.0 in 2022, then fell by 10.78% to $278153.5 in 2023, then tumbled by 36.02% to $177959.5 in 2024, then advanced by 13.59% to $202142.0 in 2025.
• The last three Assets Average figures came in at $202142.0 (Q4 2025), $188339.0 (Q3 2025), and $185025.5 (Q2 2025), per Business Quant data.